Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    DEN170044
    Device Name
    ClearMate
    Date Cleared
    2019-03-14

    (573 days)

    Product Code
    Regulation Number
    868.5480
    Type
    Direct
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K953107, K142402, K912203, K161420

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    ClearMate™ is intended to be used by emergency department medical professionals as an adjunctive treatment for patients suffering from carbon monoxide poisoning. The use of ClearMate" enables accelerated elimination of carbon monoxide from the body by allowing isocapnic hyperventilation through simulated partial rebreathing.

    Device Description

    This device is intended to induce isocapnic hyperventilation in patients to speed up elimination of carbon monoxide (CO). Isocapnic hyperventilation can be defined as large increases in patient minute volume with minimal changes in arterial partial pressure of carbon dioxide (CO2). This device replaces CO2 levels in the airway, thereby maintaining CO2 levels in the blood that ultimately causes hyperventilation. This pneumatic device initially provides 100% supplemental oxygen (O2) at minute volumes selected based on patient weight. If the patient minute volume demand is more than the preset supplement O2 volume, this device supplies a mixture of 94%/6% (O2/CO2), which maintains CO2 levels in the airway to enable isocapnic breathing by partial simulated rebreathing (of CO2). This device consists of:

    1. The subject of this De Novo, the Control unit ("briefcase"), connects to sources of O2 and CO2 (neither gas is supplied with this device). The unit includes pressure gauges to read the source gas pressures. Internal components control supplemental gas flowrates, gas concentrations, and CO2 diversion away from the gas delivery pathway should O2 pressures be insufficient. This unit weighs about 2 kg and is pneumatically driven (i.e., no electronics).
    2. Two breathing circuits, which are not the subject of this De Novo, can attach to the gas outlet ports of the control unit. These circuits are constructed of reservoir bags (21 CFR 868.5320, Class I), oxygen cannulas (21 CFR 868.5340, Class I), masks (21 CFR 868.5550, cleared under K953107), valves (21 CFR 868.5870, cleared under K142402), resuscitation bags (21 CFR 868.5915, cleared under K912203), and/or tubing (21 CFR 868.5925, cleared under K161420).
    3. Hoses for source gas connections and a device stand for steadying the device, which are a subject of this De Novo.
    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study information for the ClearMate device, based on the provided text:

    Acceptance Criteria and Device Performance

    Acceptance Criteria (Special Controls - 21 CFR 868.5480)Reported Device Performance
    Non-clinical performance testing demonstrates device performs as intended under anticipated conditions of use, including:Verified through bench testing.
    A. Gas concentration accuracy testing for the range of intended concentrations;Control Unit Performance: Ten control units were tested. "Operation of supplemental O2 concentration, blended gas concentrations... All predefined specifications were met."
    B. Airway pressure delivery accuracy testing;Breathing Circuit Performance: "One-way valves (e.g., relief valves, demand valves) were individually tested for minimum pressure responses. Testing validated the worst case range of pressures experienced in the circuits, leakage rate of the circuit... All predefined specifications were met." Control Unit Performance: Not directly mentioned, but implied through the overall performance of the circuits.
    C. Supplemental O2 flowrate accuracy testing;Breathing Circuit Performance: "Supplemental O2 flowrate accuracy specifications. Circuits were tested to facilitate the correct gas concentrations output by the control unit... All predefined specifications were met." Control Unit Performance: "Supplemental O2 flowrate accuracy. All predefined specifications were met."
    D. Alarm testing;Control Unit Performance: Ten control units were tested. "Low O2 pressures (upper and lower limits) that trigger the CO2-driven alarm. CO2 diversion to drive the alarm... All predefined specifications were met."
    E. Use life testing.Use life Performance: Challenged 5 device samples at double the typical maximum breaths per minute and 1.4 times the typical adult tidal volume for 10 hours (simulating 8 patients/year over 5 years). "The results confirm supplemental O2 output and O2/CO2 demand valve operating specifications, which are the components subjected to most repeated use over the use life."
    The patient-contacting components of the device must be demonstrated to be biocompatible.Biocompatibility/Materials: A biological risk assessment was performed in accordance with ISO 10993-1. Components (face mask, adapters, resuscitation bag, leaflet valve) were either previously cleared with similar biocompatibility concerns or tested for dry gas pathway concerns (particulate matter and VOCs). "Based on the submitted testing and evaluations, the applicant has demonstrated device biocompatibility for this intended use."
    Labeling must include:Labeling is required to inform proper use.
    A. Instructions for use;Required.
    B. A precaution that monitoring of capnography is necessary during treatment with nonspontaneously breathing patients; andRequired. "When providing treatment to a non-spontaneously breathing patient using the ClearMate™ non-spontaneous breathing patient circuit, CO2 monitoring equipment for the measurement of expiratory carbon dioxide concentration must be used." and "A precaution that monitoring of capnography is necessary during treatment with nonspontaneously breathing patients."
    C. Use life specification.Required. "The applicant proposed a 5-year use life."

    Study Information

    2. Sample Size Used for the Test Set and Data Provenance:

    The document primarily discusses preclinical (animal and bench) and clinical literature review, rather than a single prospective "test set" for the device itself in the traditional sense of an AI/algorithm.

    • Bench Testing:

      • Breathing Circuit Performance: 10 samples of spontaneously breathing circuits and 10 samples of non-spontaneously breathing circuits (20 samples total).
      • Control Unit Performance: 10 control units.
      • Use Life Performance: 5 device samples.
      • Data Provenance: Retrospective, conducted by the applicant (Thornhill Research, Inc.) presumably in Canada (given the contact address is in Scottsdale, AZ, but the company is Thornhill Research, Inc., which is Canadian). This is inferred as internal testing presented to the FDA.
    • Animal Studies:

      • Fisher JA et al. (1999): Dog model (specific N not provided in the summary). Provenance: Published U.S. study.
      • Krech T et al. (2001): Mechanically ventilated sheep (specific N not provided in the summary). Provenance: Published U.S. study.
    • Human Clinical Literature Review (considered as evidence of effectiveness):

      • Anand et al. (2017): 13 healthy volunteers (chronic smokers). Provenance: Published study (journal name "PLOS One" suggests an international publication, DOI:10.1371/journal.pone.0170621).
      • Rucker et al. (2002): 14 healthy volunteers. Provenance: Published U.S. study.
      • Takeuchi et al. (2000): Healthy human volunteers (specific N not provided in the summary). Provenance: Published U.S. study.
      • Katznelson et al. (2008): Specific N not provided in the summary (anesthetic agents study). Provenance: Published study.
      • Katznelson et al. (2011): 44 obese elective surgical patients (anesthetic agents study). Provenance: Published study.
      • Wu et al. (2015) - external study, not used for efficacy but for safety: 319 patients in treatment group, 320 in control group. Provenance: Chinese study, published in "Chinese Journal of Clinicians."

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:

    This device is not an AI/algorithm requiring expert-established ground truth for a test set in the diagnostic sense. The "ground truth" for its performance is derived from:

    • Bench Testing: Engineering specifications and physical measurements. Experts involved would be engineering and quality control personnel. Their specific qualifications are not detailed, but they would be presumed to be qualified engineers/technicians.
    • Animal Studies: Scientific observation and measurement by researchers/veterinarians.
    • Human Clinical Studies: Clinical endpoints (e.g., COHb levels, elimination half-life, cerebral blood flow) measured by medical professionals and researchers. The peer-review process for these published studies implicitly involves expert clinicians and scientists.

    4. Adjudication Method for the Test Set:

    Not applicable, as this is not an AI/diagnostic algorithm using expert review for a "test set." For the literature review, the FDA's internal review team served as the adjudicators of the existing scientific evidence.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done:

    No, an MRMC comparative effectiveness study, in the context of human reader performance with/without AI assistance, was not performed. The device is a physical therapeutic device, not a diagnostic AI system intended to assist human readers.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    Yes, the device itself is the "standalone" component. Its performance was evaluated independently through bench testing (as detailed in item #2) and animal studies. The human clinical studies also assess the device's effect on physiological markers when used therapeutically.

    7. The Type of Ground Truth Used:

    • Bench Testing: Device specifications, physical properties, engineering standards, and direct measurement of gas concentrations, flow rates, and pressures.
    • Animal Studies: Physiological measurements (e.g., COHb levels, cardiac output, oxygen delivery) directly measured from the animal subjects.
    • Human Clinical Studies (for effectiveness): Physiological measurements (e.g., COHb levels, elimination half-life, cerebral blood flow) obtained from human volunteers or patients using established medical measurement techniques.
    • Human Clinical Study (Wu et al. for safety, but with limitations on efficacy): Clinical outcomes adjudicated by medical personnel based on consciousness, continence, disappearance of CO poisoning signs, EEG findings, and BI (Barthel Index) scores.

    8. The Sample Size for the Training Set:

    Not applicable. This is a physical medical device, not an AI model requiring a training set in the machine learning sense. The device's design is based on scientific principles of isocapnic hyperventilation, not data training.

    9. How the Ground Truth for the Training Set was Established:

    Not applicable (as above). The design and performance targets for the ClearMate device are based on established physiological principles and engineering requirements, not on a "ground truth" derived from a training dataset for an AI algorithm.

    Ask a Question

    Ask a specific question about this device

    K Number
    K152521
    Date Cleared
    2016-06-03

    (274 days)

    Product Code
    Regulation Number
    868.5870
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K142402, K842693

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Seal Rite Non-Rebreathing Valve is a single-use, non-sterile device intended to be used with a ventilation mask (without oxygen port) to provide mouth-to-mask ventilation to health emergency victims requiring cardiopulmonary resuscitation ("CPR") rescue techniques. It is intended for over-the-counter use.

    Device Description

    The Seal Rite™ Non-Rebreathing Valve ("Seal Rite Valve") is a resuscitation valve designed for resuscitation using expired air for ventilation. It has fittings on the grooved patient end that will adapt to standard masks (22 mm ID) used for resuscitation. The Seal Rite Valve allows the rescuer to blow air into a mask through its silicone one-way valve and directs the patient's exhaled air away from the rescuer via a rigid one-way valve and multiple exhaust ports. The Seal Rite Valve helps protect the rescuer from potential patient contamination. The Seal Rite Valve does not have an oxygen port.

    AI/ML Overview

    The provided text is a 510(k) summary for the Seal Rite Non-Rebreathing Valve (K152521). It describes the device, its intended use, and the testing conducted to establish its substantial equivalence to a predicate device.

    Here's an analysis of the acceptance criteria and study information based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The device was tested to ensure conformance with the FDA Recognized AS 4259-1995 standard ("Ancillary devices for expired air resuscitation") and passed all testing requirements. The table below summarizes the key performance parameters tested and the reported results. The explicit acceptance criteria (e.g., maximum allowable resistance values per the standard) are not fully detailed in the provided text, but the text states that the device "passed all testing requirements" and "performs as intended and meets the requirements of the AS 4259-1995 standard." I've extracted specific quantitative performance values where available and indicated "Pass" for qualitative tests.

    Acceptance Criteria (Implied by standard AS 4259-1995)Reported Device Performance (Seal Rite™ Non-Rebreathing Valve)Predicate Device Performance (Respironics Rescue Valve)
    Biocompatibility:
    Meet Cytotoxicity requirements (ISO 10993-5)PassNot explicitly stated for predicate in this document
    Meet Irritation requirements (ISO 10993-10)PassNot explicitly stated for predicate in this document
    Meet Sensitization requirements (ISO 10993-12)PassNot explicitly stated for predicate in this document
    Bench Testing (Functional Performance/Conformity to AS 4259-1995):
    Ventilation Performance requirementsPassNot explicitly stated for predicate in this document
    Expiratory Resistance for the Patient requirementsPassNot explicitly stated for predicate in this document
    Expiratory Resistance for the Rescuer requirementsPassNot explicitly stated for predicate in this document
    Inspiratory Resistance for a Spontaneously Breathing Patient requirementsPassNot explicitly stated for predicate in this document
    Function After Contamination with Stomach Contents requirementsPassNot explicitly stated for predicate in this document
    Function After Immersion in Water requirementsPassNot explicitly stated for predicate in this document
    Measurement of Dead Space requirementsPassNot explicitly stated for predicate in this document
    Resistance to Disengagement of Parts requirementsPassNot explicitly stated for predicate in this document
    High and Low Storage Conditions requirementsPassNot explicitly stated for predicate in this document
    High Temperature Operation requirementsPassNot explicitly stated for predicate in this document
    Low Temperature Operation requirementsPassNot explicitly stated for predicate in this document
    Attempted Displacement of Valve by Finger, Function After Dropping, Function After Potentially Deforming Weight requirementsPassNot explicitly stated for predicate in this document
    Conformance of Connectors requirementsPassNot explicitly stated for predicate in this document
    ISTA Procedure 2A Shipping Testing requirementsPassNot explicitly stated for predicate in this document
    Expiratory Resistance at 50 LPM0.327 cm H2O (0.0321 kPa)0.25 cm H2O at 50 LPM (per K142402 510(k) Summary)
    Inspiratory Resistance at 50 LPM1.15 cm H2O (0.113 kPa)1.85 cm H2O at 50 LPM (per K142402 510(k) Summary)
    Inlet ConnectorStandard 22 mm IDStandard 22 mm ID
    Outlet ConnectorStandard 22 mm OD/15 mm IDStandard 22 mm OD/15 mm ID

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the sample sizes for the non-clinical tests (biocompatibility and bench testing). It mentions that the testing was conducted according to recognized standards (FDA Blue Book Memo G95-1, ISO 10993 series, AS 4259-1995, ISTA Procedure 2A). Typically, these standards specify the number of samples required for each test. The data provenance is implied to be from laboratory testing as mandated by these standards, not from human subjects or real-world use. It is retrospective in the sense that the testing was performed to support the 510(k) submission.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This information is not applicable as the evaluation relies on a non-clinical, benchtop and laboratory testing against established engineering and biocompatibility standards, not on expert interpretation of medical data.

    4. Adjudication Method for the Test Set

    This information is not applicable as the evaluation relies on a non-clinical, benchtop and laboratory testing against established engineering and biocompatibility standards. There is no human adjudication process described.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

    This information is not applicable. The Seal Rite Non-Rebreathing Valve is a mechanical medical device, not an AI or imaging diagnostic tool. Therefore, an MRMC study with human readers (or AI assistance) would not be relevant.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This information is not applicable as the device is a mechanical non-rebreathing valve, not an algorithm or AI system. The performance evaluated is the standalone performance of the physical device according to engineering and biocompatibility standards.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance is based on established engineering standards and biocompatibility standards. Specifically:

    • AS 4259-1995: "Ancillary devices for expired air resuscitation"
    • FDA Blue Book Memo G95-1: Guidance for biocompatibility testing.
    • ISO 10993-5: Biocompatibility testing (Cytotoxicity)
    • ISO 10993-10: Biocompatibility testing (Irritation)
    • ISO 10993-12: Biocompatibility testing (Sensitization)
    • ISTA Procedure 2A: Shipping testing.

    These standards define the acceptable performance parameters and test methods for such devices.

    8. The Sample Size for the Training Set

    This information is not applicable. The device is a mechanical non-rebreathing valve, not a machine learning model. Therefore, there is no "training set."

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable as there is no training set for this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1